Regeneron Buys 23andMe for $256 Million
SAN FRANCISCO -- Regeneron Pharmaceuticals, a NY-based, biotechnology company -- is buying bankrupt 23andMe for…
News
News
NVIDIA
NVIDIA Introduces NVLink Fusion
At the Computex trade show in Taiwan, NVIDIA unveiled NVIDIA NVLink Fusion — new silicon…